Are ceramides toxic

Stable protective layer

literature

[1] Wollenberg A, Barbarot S, Bieber T et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol 2018; 32: 657-682

[2] Werfel T, Aberer W, Ahrens F et al. Guideline atopic dermatitis. AWMF register 013/027, as of March 31, 2015, www.awmf.org

[3] Winterhagen I. Consultation practice at neurodermatitis. Deutscher Apotheker Verlag, Stuttgart 2010

[4] Simpson EL, Chalmers JR, Hanifin JM et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol 2014; 134: 818-823

[5] Horimukai K, Morita K, Narita M et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol 2014; 134: 824-830

[6] Wiren K, Nohlgard C, Nyberg F et al. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. J Eur Acad Dermatol Venereol 2009; 23: 1267-1272

[7] Grimalt R, Mengeaud V, Cambazard F, Study Investigators Group. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology 2007; 214: 61-67

[8] Szczepanowska J, Reich A, Szepietowski JC. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study. Pediatr Allergy Immunol 2008; 19: 614-618

[9] Eberlein B, Eicke C, Reinhardt HW, Ring J. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol 2008; 22: 73-82

[10] Akerstroem U, Reitamo S, Langeland T et al. Comparison of moisturizing creams for the prevention of atopic dermatitis relapse: a randomized double-blind controlled multicentre clinical trial. Acta Derm Venereol 2015; 95: 587-592

[11] Mengeaud V, Phulpin C, Bacquey A, Boralevi F, Schmitt AM, Taieb A. An innovative oat-based sterile emollient cream in the maintenance therapy of childhood atopic dermatitis. Pediatr Dermatol 2015; 32: 208-215

[12] Wohlrab J, Klauck D, Savtcheva E. Regulatory requirements for topical preparations. Dermatologist 2014; 65 (3): 175-9

[13] Kresken J, Wollenberg A, Hünerbein A, Staubach P. Topical basic therapy for neurodermatitis - evidence-based advice in pharmacies. Statement of the GD Gesellschaft für Dermopharmazie e. V., June 26, 2019. www.gd-online.de

[14] Van Zuuren EJ et al. Emollients and moisturizers for eczema. Cochrane Database of Systematic Reviews 2017; 2: Art.No CD012110

[15] Mengeaud V, Phulpin C, Bacquey A, et al. An innovative oat-based sterile emollient cream in the maintenance therapy of childhood atopic dermatitis. Pediatr Dermatol 2015; 32: 208-215

[16] Gueniche A et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. Br J Deratol 2008; 159 (6): 1357-1363

[17] Bianchi P, Theunis J, Casas C et al. Effects of a new emollient-based treatment on skin microflora balance and barrier function in children with mild atopic dermatitis. Pediatr Dermatol 2016; 33: 165-171

[18] Santer M et al. Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomized controlled trial of clinical and cost effectiveness. BMJ 2018; doi: 10.1136 / bmj.k1332

[19] Heine G, Schnuch A, Uter W, Worm M. Type-IV sensitization profile of individuals with atopic eczema: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG). Allergy 2006; 61: 611-616

[20] Heine G, Schnuch A, Uter W, Worm M. Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group. Contact Dermatitis 2004; 51: 111-117

[21] Thyssen JP, Linneberg A, Engkilde K et al. Contact sensitization to common haptens is associated with atopic dermatitis: new insight. Br J Dermatol 2012; 166: 1255-1261

[22] Enzel U. Update Neurodermatitis - Proven and new information on care and therapy from the pharmacy's treasure, lecture by the State Chamber of Pharmacists (LAK), Stuttgart, October 18, 2018

[23] Schürer N, Kresken J. The dry skin. Scientific publishing company, Stuttgart 2000

[24] Loden M, Andersson AC, Lindberg M. The effect of two urea-containing creams on dry, eczematous skin in atopic patients. II. Adverse effects. Journal of Dermatological Treatment 1999; 10: 171-75

[25] Boralevi F, Saint Aroman M, Delarue A, et al. Long-term emollient therapy improves xerosis in children with atopic dermatitis. J Eur Acad Dermatol Venereol 2014; 28: 1456-1462

[26] Loden M, Andersson AC, Anderson C et al. A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients. Acta Derm Venereol 2002; 82: 45-47

[27] Tiplica GS, Boralevi F, Konno P et al. The regular use of an emollient improves symptoms of atopic dermatitis in children - randomized controlled study. J Eur Acad Dermatol Venereol 2018; 32: 1180-1187

[28] Rossi AB, Bacquey A, Nocera T et al. Efficacy and tolerability of a medical device repairing emollient cream associated with a topical corticosteroid in adults with atopic dermatitis - an open-label, intra-individual randomized controlled study. Dermatol Ther (Heidelb) 2018; 8: 217-228

[29] Anstey A, Quigley M, Wilkinson J. Topical evening primrose oil as treatment for atopic eczema. J Dermatol Treat 1990; 1: 199-201

[30] Gehring W, Bopp R, Rippke F, Gloor M. Effect of topically applied evening primrose oil on epidermal barrier function in atopic dermatitis as a function of vehicle. Drug Research 1999; 49: 635-642

[31] Ernst E. Adverse effects of herbal drugs in dermatology. Br J Dermatol 2000; 143: 923-929

[32] Giordano-Labadie F, Schwarze HP, Bazex J. Allergic contact dermatitis from camomile used in phytotherapy. Contact Dermatitis 2000; 42: 247

[33] Wollenberg A, Barbarot S, Bieber T et al. Consensus-based European guidelines for traetment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol 2018; 32: 850-878

[34] Hauss H, Proppe A, Matthies C. A formulation for the treatment of dry, itching skin in comparison - results from therapeutic use. Occupational and Environmental Dermatoses 1993; 41: 184-88

[35] Wohlrab J, Staubach P. Augustin M et al. For the use of preparations for local application on the skin (topicals). S2k guideline of the German Dermatological Society (DDG) and the professional association of German dermatologists e. V. (BVDD), as of November 1, 2017, AWMF register number 013-092, www.awmf.org

[36] Ferreira M, Fiadeiro T, Silva M, Soares A. Topical gamma-linolenic acid therapy in atopic dermatitis. A clinical and biometric evaluation. Allergo J 1998; 7: 213-216

[37] Roos TC, Brost H. Neurodermatitis: Stopping itching and skin inflammation. S. Hirzel Verlag, Stuttgart 2004